| Bioactivity | Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary drug conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors[1][2][3]. | ||||||
| Name | Certepetide | ||||||
| CAS | 2580154-02-3 | ||||||
| Shortening | Ac-CRGDKGPDC-NH2 (Disulfide bridge: Cys1-Cys9) | ||||||
| Formula | C37H60N14O14S2 | ||||||
| Molar Mass | 989.09 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Certepetide
CAS: 2580154-02-3 F: C37H60N14O14S2 W: 989.09
Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.